帝王国际投资(00928)上涨92.86%,报0.054元/股

金融界
11 Mar

3月11日,帝王国际投资(00928)盘中上涨92.86%,截至10:06,报0.054元/股,成交102.42万元。

帝王国际投资有限公司是一家集中于提供肿瘤精准医疗基因检测服务的公司, 主要产品涉及各类肿瘤的全病程管理,旨在为临床医生和病患提供辅助诊断和疗程规划解决方案。公司凭借在华南地区设立的广州莲和医疗中心实验室,以及符合国内外标准的质量管理系统,持续在国际质量评估中取得优异成绩,确保了检测服务的专业性和准确性。

截至2024年中报,帝王国际投资营业总收入3353.4万元、净利润-143.11万元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10